title: Dapsone in the management of autoimmune bullous diseases.
abstract: Dapsone is used in the treatment of autoimmune bullous diseases (AIBD), a group of disorders resulting from autoimmunity directed against basement membrane and/or intercellular adhesion molecules on cutaneous and mucosal surfaces. This review summarizes the limited published data evaluating dapsone as a therapy for AIBD.
authors.affiliation: Department of Dermatology, Perelman Center for Advanced Medicine, Suite 1-330A, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
authors.forename: Evan W
authors.initials: EW
authors.lastname: Piette
authors.forename: Victoria P
authors.initials: VP
authors.lastname: Werth
mesh_terms: D000380:Agranulocytosis / Q000209:etiology; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D003622:Dapsone / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D019468:Disease Management; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D008708:Methemoglobinemia / Q000209:etiology; D018375:Neutrophil Activation / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy* / Q000276:immunology
chemical_list: D007917:Leprostatic Agents; D003622:Dapsone